Topics:

GE

GE

Where did tomosynthesis come from and where is it going? Here, a tomosynthesis pioneer discusses its evolution.

GE’s SenoClaire breast tomosynthesis solution will join Hologic, the only other vendor with FDA approval for 3D mammography.

As breast imaging technology advances, providers are looking to vendors to help meet their needs. Find out here which vendors are favored.

With patient satisfaction an increasing concern, radiology vendors and facilities are focused on improving the imaging experience.

GE Healthcare’s Vizamyl, for PET imaging of the brain to estimate beta amyloid neuritic plaque density in cognitively impaired adults, introduced in 7 markets.

The FDA has approved GE Healthcare’s Q.Clear, a technology that GE says improves accuracy when assessing a patient’s response to treatment.

FDA approved GE Healthcare's radioactive diagnostic drug Vizamyl for use with PET scans in patients with Alzheimer's disease and dementia.

Pages

Subscribe to GE on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.